SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950130-03-001872
Filing Date
2003-03-07
Accepted
2003-03-07 11:09:20
Documents
8
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1507207
3 CERTIFICATE OF DESIGNATIONS OF SERIES H PREFERRED STOCK dex33.htm EX-3.3 37129
4 FIRST AMENDMENT TO LEASE AGREEMENT INSPIRE PHARMACEUTICALS AND ROYAL CENTER dex1031.htm EX-10.31 31198
5 THIRD AMENDMENT TO LEASE AGREEMENT INSPIRE PHARMACEUTICALS AND ROYAL CENTER dex1032.htm EX-10.32 29988
6 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex231.htm EX-23.1 1764
7 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER dex991.htm EX-99.1 4176
8 CERTIFICATION OF THE PRESIDENT, SECRETARY AND TREASURER dex992.htm EX-99.2 4426
9 GRAPHIC g97087g17a25.jpg GRAPHIC 83024
  Complete submission text file 0000950130-03-001872.txt   1701429
Mailing Address 4222 EMPEROR BLVD STE 470 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 470 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE
Type: 10-K | Act: 34 | File No.: 001-31577 | Film No.: 03595550
SIC: 2834 Pharmaceutical Preparations